Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:actsOn |
norepinephrine reuptake inhibitor
dopamine reuptake inhibitor |
| gptkbp:alsoKnownAs |
2-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-4,6-dimethyl-1,3,5-triazine
|
| gptkbp:canBe |
antidepressant
treatment of psychiatric disorders |
| gptkbp:CASNumber |
213007-95-1
|
| gptkbp:chemicalFormula |
C17H24N6O
|
| gptkbp:developedBy |
research chemical
|
| gptkbp:drugClass |
triple reuptake inhibitor
|
| gptkbp:hasInChIKey |
QJQJQJQJQJQJQJ-QWOVJNBASA-N
|
| gptkbp:hasPiperazineRing |
true
|
| gptkbp:hasSMILES |
CC1=NC(=NC(=N1)N2CCN(CC2)C3=CC=CC=C3OC)C
|
| gptkbp:hasTriazineRing |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
PF-39
|
| gptkbp:isNotApprovedForMedicalUse |
true
|
| gptkbp:IUPACName |
2-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-4,6-dimethyl-1,3,5-triazine
|
| gptkbp:molecularWeight |
328.42 g/mol
|
| gptkbp:PubChem_CID |
9793932
CHEMBL210386 |
| gptkbp:bfsParent |
gptkb:USS_Virgin_Islands
|
| gptkbp:bfsLayer |
7
|